查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1753971

2025 年至 2033 年冠状动脉支架市场报告（按类型、生物材料、交付方式、最终用户和地区）

Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球冠状动脉支架市场规模达117亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到189亿美元，2025-2033年期间的复合年增长率（CAGR）为5.18%。该市场正在经历显着增长，主要原因是心血管疾病患病率上升、支架技术进步以及老龄人口增长。新兴市场和技术创新（例如生物可吸收支架）进一步推动了全球市场的成长。

冠状动脉支架是一种小型自膨胀管状金属装置，在球囊血管成形术后置入狭窄的冠状动脉内，以保持动脉通畅。这些支架表面涂有药物，药物会缓慢释放，防止动脉壁斑块堆积和再次狭窄。它们还能缓解心臟病症状，例如胸痛和呼吸急促，并维持血液和氧气正常流向心臟。由于冠状动脉支架具有微创（MI）特性且恢復时间较短，因此在世界各地，它正逐渐取代冠状动脉绕道手术。

冠状动脉支架市场趋势：

药物洗脱支架（DES）日益受到青睐

药物洗脱支架 (DES) 因其在减少再狭窄（即支架置入后动脉再次变窄）方面的有效性，正成为比裸金属支架 (BMS) 更受欢迎的选择。这些支架上涂有缓慢释放的药物，可防止动脉内形成瘢痕组织，显着降低阻塞风险。例如，2024 年 5 月，雅培在印度推出了 XIENCE Sierra 依维莫司洗脱冠状动脉支架系统，该系统采用增强型支架设计，配备新的输送系统和独特的尺寸，有助于治疗复杂病例。该支架采用特殊涂层，可减少动脉再次阻塞，并已证明其在治疗棘手病变和复杂病症方面有效。与此一致，临床研究表明，与 BMS 相比，DES 可减少重复手术的需求，从而改善长期疗效。根据冠状动脉支架市场分析，由于药物洗脱支架（DES）在减少再狭窄和长期併发症方面的卓越性能，其采用率高于裸金属支架，因此市场将实现显着增长。

技术进步

冠状动脉支架的技术进步包括生物可吸收支架的开发，该支架在完成工作后即可溶解，从而消除了长期植入的需求，并降低了晚期支架内血栓形成等风险。例如，2024年7月，微创医疗科学有限公司的Firesorb(R)生物可吸收心臟支架获得中国国家药品监督管理局的批准。此支架在临床研究中表现出色，标靶病变失败率和血栓形成率较低。药物涂层球囊是另一项创新技术，可将药物直接输送至动脉，不留下永久性装置，通常适用于复杂病变或再狭窄风险较高的患者。这些技术旨在透过减少长期併发症、促进血管癒合以及在冠状动脉介入治疗中提供更个人化的治疗方案来改善患者预后。

老年人口增长及心血管疾病发生率上升

随着全球老年人口的不断增长，心血管疾病，特别是冠状动脉疾病的发生率也在上升。根据世界卫生组织 (WHO) 发布的报告，到 2030 年，每 6 个人中就有 1 个人年龄超过 60 岁，全球老龄人口将达到 14 亿。到 2050 年，这一数字将翻一番，达到 21 亿，其中 4.26 亿人年龄在 80 岁或以上。由于胆固醇积聚等与年龄相关的因素，动脉会变硬变窄，因此越来越需要接受冠状动脉介入治疗。老年人群更容易患心臟病，这推动了对冠状动脉支架的需求，以恢復血流并预防心臟病发作等併发症。支架技术的进步，加上老年患者对安全、有效的治疗的需求，大大促进了冠状动脉支架市场的成长。全球预期寿命的延长和医疗服务可近性的改善进一步推动了这项需求。

本报告回答的关键问题

  • 2024年全球冠状动脉支架市场规模？ 2025-2033年全球冠状动脉支架市场的预期成长率是多少？
  • 推动全球冠状动脉支架市场的关键因素有哪些？
  • COVID-19 对全球冠状动脉支架市场有何影响？
  • 全球冠状动脉支架市场依类型分为哪些类型？
  • 根据生物材料，全球冠状动脉支架市场如何分布？
  • 根据交付方式，全球冠状动脉支架市场如何分布？
  • 根据最终用户，全球冠状动脉支架市场的分布如何？
  • 全球冠状动脉支架市场的主要区域有哪些？
  • 全球冠状动脉支架市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球冠状动脉支架市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 药物洗脱支架
  • 裸金属冠状动脉支架
  • 生物可吸收支架

第七章：市场区隔：依生物材料

  • 金属生物材料
  • 聚合物生物材料
  • 天然生物材料

第八章：市场区隔：依交付方式

  • 球囊扩张支架
  • 自膨式支架

第九章：市场区隔：依最终用户

  • 医院
  • 门诊手术中心
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Elixir Medical Corporation
    • Lepu Medical Technology (Beijing) Co. Ltd.
    • Medtronic plc
    • Meril Life Sciences Pvt. Ltd.
    • MicroPort Scientific Corporation
    • Terumo Corporation
    • Translumina GmbH
Product Code: SR112025A6083

The global coronary stents market size reached USD 11.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.18% during 2025-2033. The market is experiencing significant growth mainly driven by the rising prevalence of cardiovascular diseases, advancements in stent technology and a growing elderly population. Emerging markets and technological innovations, such as bioresorbable stents, further propels market growth across the globe.

Coronary stents are small, self-expanding tubular metallic devices introduced inside narrow coronary arteries to keep them open after a balloon angioplasty procedure. These stents are coated with a medication, which is slowly released to prevent the walls of arteries from plaque buildup and re-narrowing. They also alleviate heart disease symptoms, such as chest pain and shortness of breath, and allow normal flow of blood and oxygen to the heart. As they are minimally invasive (MI) and require shorter recovery time, coronary stents are gaining traction over coronary artery bypass surgeries around the world.

Coronary Stents Market Trends:

Rising Preference for Drug-Eluting Stents (DES)

Drug-eluting stents (DES) are becoming the preferred option over bare-metal stents (BMS) due to their effectiveness in reducing restenosis which is the re-narrowing of arteries after stenting. These stents are coated with medication that is slowly released to prevent the formation of scar tissue within the artery, thus significantly lowering the risk of blockages. For instance, in May 2024, Abbott introduced the XIENCE Sierra Everolimus eluting coronary stent system in India offering enhanced stent design with a new delivery system and unique sizes to aid in treating complex cases. The stent features a specialized coating to reduce artery re-blocking and has demonstrated efficacy in challenging lesions and complex conditions. In line with this, clinical studies have shown that DES improves long-term outcomes by reducing the need for repeat procedures compared to BMS. According to coronary stents market analysis, the market is set for significant growth due to the rising adoption of drug-eluting stents (DES) over bare-metal stents mainly driven by their superior performance in reducing restenosis and long-term complications.

Technological Advancements

Technological advancements in coronary stents include the development of bioresorbable stents which dissolve after their job is done, thus eliminating the need for long-term implants and reducing risks like late stent thrombosis. For instance, in July 2024, MicroPort Scientific Corporation's Firesorb(R) bioresorbable cardiac stent gained approval from the National Medical Products Administration in China. The stent has shown exceptional performance in clinical studies, with low rates of target lesion failure and thrombosis. Drug-coated balloons are another innovation that deliver drugs directly to the artery without leaving behind a permanent device generally ideal for complex lesions or patients with higher risks of restenosis. These technologies aim to improve patient outcomes by reducing long-term complications, enhancing vessel healing, and offering more personalized treatment options in coronary interventions.

Growing Geriatric Population and Rise of Cardiovascular Diseases

With the rising global geriatric population, the prevalence of cardiovascular diseases, particularly coronary artery disease, is on the rise. According to the report published by World Health Organization (WHO), by 2030, 1 in 6 people will be over 60 years old, and there will be 1.4 billion older individuals. By 2050, this number will double to 2.1 billion, with 426 million aged 80 or older. As arteries harden and narrow due to age-related factors like cholesterol buildup, elderly individuals are increasingly requiring coronary interventions. The higher susceptibility to heart conditions among this group drives the demand for coronary stents to restore blood flow and prevent complications like heart attacks. Advancements in stent technology combined with the need for safe more effective treatments in older patients, are contributing significantly to the coronary stents market growth. This demand is further fuelled by extended life expectancy and improved access to healthcare globally.

Key Market Segmentation:

Breakup by Type:

  • Drug-eluting Stents
  • Bare-metal Coronary Stents
  • Bioabsorbable Stents

Breakup by Biomaterial:

  • Metallic Biomaterial
  • Polymeric Biomaterial
  • Natural Biomaterial

Breakup by Mode of Delivery:

  • Balloon-expandable Stents
  • Self-expanding Stents

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global coronary stents market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Translumina GmbH

Key Questions Answered in This Report

  • 1.What was the size of the global coronary stents market in 2024?
  • 2.What is the expected growth rate of the global coronary stents market during 2025-2033?
  • 3.What are the key factors driving the global coronary stents market?
  • 4.What has been the impact of COVID-19 on the global coronary stents market?
  • 5.What is the breakup of the global coronary stents market based on the type?
  • 6.What is the breakup of the global coronary stents market based on biomaterial?
  • 7.What is the breakup of the global coronary stents market based on the mode of delivery?
  • 8.What is the breakup of the global coronary stents market based on the end user?
  • 9.What are the key regions in the global coronary stents market?
  • 10.Who are the key players/companies in the global coronary stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Coronary Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Drug-eluting Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bare-metal Coronary Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bioabsorbable Stents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Biomaterial

  • 7.1 Metallic Biomaterial
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymeric Biomaterial
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Natural Biomaterial
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Mode of Delivery

  • 8.1 Balloon-expandable Stents
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Self-expanding Stents
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Biotronik SE & Co. KG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 SWOT Analysis
    • 15.3.4 Boston Scientific Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Elixir Medical Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Lepu Medical Technology (Beijing) Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Meril Life Sciences Pvt. Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 MicroPort Scientific Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Terumo Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Translumina GmbH
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Coronary Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Coronary Stents Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Coronary Stents Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Coronary Stents Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Coronary Stents Market: Breakup by Biomaterial (in %), 2024
  • Figure 6: Global: Coronary Stents Market: Breakup by Mode of Delivery (in %), 2024
  • Figure 7: Global: Coronary Stents Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Coronary Stents Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Coronary Stents (Drug-eluting Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Coronary Stents (Drug-eluting Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Coronary Stents (Bare-metal Coronary Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Coronary Stents (Bare-metal Coronary Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Coronary Stents (Bioabsorbable Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Coronary Stents (Bioabsorbable Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Coronary Stents (Metallic Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Coronary Stents (Metallic Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Coronary Stents (Polymeric Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Coronary Stents (Polymeric Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Coronary Stents (Natural Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Coronary Stents (Natural Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Coronary Stents (Balloon-expandable Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Coronary Stents (Balloon-expandable Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Coronary Stents (Self-expanding Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Coronary Stents (Self-expanding Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Coronary Stents (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Coronary Stents (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Coronary Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Coronary Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Coronary Stents (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Coronary Stents (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: North America: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: North America: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: United States: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: United States: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Canada: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Canada: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Asia-Pacific: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Asia-Pacific: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: China: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: China: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Japan: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Japan: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: India: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: India: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: South Korea: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: South Korea: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Australia: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Australia: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Indonesia: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Indonesia: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Europe: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Europe: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Germany: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Germany: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: France: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: France: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United Kingdom: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United Kingdom: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Italy: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Italy: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Spain: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Spain: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Russia: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Russia: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Latin America: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Latin America: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Brazil: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Brazil: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Mexico: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Mexico: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Middle East and Africa: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Middle East and Africa: Coronary Stents Market: Breakup by Country (in %), 2024
  • Figure 79: Middle East and Africa: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Global: Coronary Stents Industry: SWOT Analysis
  • Figure 81: Global: Coronary Stents Industry: Value Chain Analysis
  • Figure 82: Global: Coronary Stents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Coronary Stents Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Coronary Stents Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Coronary Stents Market Forecast: Breakup by Biomaterial (in Million USD), 2025-2033
  • Table 4: Global: Coronary Stents Market Forecast: Breakup by Mode of Delivery (in Million USD), 2025-2033
  • Table 5: Global: Coronary Stents Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Coronary Stents Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Coronary Stents Market: Competitive Structure
  • Table 8: Global: Coronary Stents Market: Key Players